KR20070027554A - 1,4-디페닐 아제티딘온 유도체의 제조방법 - Google Patents

1,4-디페닐 아제티딘온 유도체의 제조방법 Download PDF

Info

Publication number
KR20070027554A
KR20070027554A KR1020067024431A KR20067024431A KR20070027554A KR 20070027554 A KR20070027554 A KR 20070027554A KR 1020067024431 A KR1020067024431 A KR 1020067024431A KR 20067024431 A KR20067024431 A KR 20067024431A KR 20070027554 A KR20070027554 A KR 20070027554A
Authority
KR
South Korea
Prior art keywords
alkyl
formula
aryl
benzyl
xii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020067024431A
Other languages
English (en)
Korean (ko)
Inventor
안드레아스 린덴슈미트
데이비드 윌리암 윌
게르하르트 야에네
테오도르 안드레아스 볼만
벤델린 프리크
베른트 윤커
데이비드 리갈
귄터 빌렌
하이너 옌드랄라
Original Assignee
사노피-아벤티스 도이칠란트 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE200410025071 external-priority patent/DE102004025071B4/de
Priority claimed from DE102005010770A external-priority patent/DE102005010770A1/de
Application filed by 사노피-아벤티스 도이칠란트 게엠베하 filed Critical 사노피-아벤티스 도이칠란트 게엠베하
Publication of KR20070027554A publication Critical patent/KR20070027554A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020067024431A 2004-05-21 2005-05-20 1,4-디페닐 아제티딘온 유도체의 제조방법 Withdrawn KR20070027554A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE200410025071 DE102004025071B4 (de) 2004-05-21 2004-05-21 Verfahren zur Herstellung von Diphenylazetidinon-Derivaten
DE102004025071.5 2004-05-21
DE102005010770A DE102005010770A1 (de) 2005-03-09 2005-03-09 Verfahren zur Herstellung von 1,4-Diphenylazetidinon-Derivaten
DE102005010770.2 2005-03-09

Publications (1)

Publication Number Publication Date
KR20070027554A true KR20070027554A (ko) 2007-03-09

Family

ID=37561403

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067024431A Withdrawn KR20070027554A (ko) 2004-05-21 2005-05-20 1,4-디페닐 아제티딘온 유도체의 제조방법

Country Status (25)

Country Link
US (1) US7488818B2 (https=)
EP (1) EP1756049B1 (https=)
JP (1) JP2007538042A (https=)
KR (1) KR20070027554A (https=)
AR (1) AR049184A1 (https=)
AT (1) ATE376997T1 (https=)
AU (1) AU2005245124A1 (https=)
BR (1) BRPI0510150A (https=)
CA (1) CA2567149A1 (https=)
CY (1) CY1107425T1 (https=)
DE (1) DE502005001841D1 (https=)
DK (1) DK1756049T3 (https=)
ES (1) ES2294712T3 (https=)
HR (1) HRP20070570T3 (https=)
IL (1) IL178991A0 (https=)
MA (1) MA28635B1 (https=)
MX (1) MXPA06013456A (https=)
NZ (1) NZ551413A (https=)
PL (1) PL1756049T3 (https=)
PT (1) PT1756049E (https=)
RS (1) RS50539B (https=)
RU (1) RU2380361C2 (https=)
TW (1) TW200611896A (https=)
UY (1) UY28912A1 (https=)
WO (1) WO2005113496A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
CN100471835C (zh) * 2003-12-23 2009-03-25 默克公司 抗高胆固醇血症化合物
EP1699759B1 (en) 2003-12-23 2010-10-20 AstraZeneca AB Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
UY29607A1 (es) 2005-06-20 2007-01-31 Astrazeneca Ab Compuestos quimicos
MY148538A (en) 2005-06-22 2013-04-30 Astrazeneca Ab Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
US20090047716A1 (en) * 2007-06-07 2009-02-19 Nurit Perlman Reduction processes for the preparation of ezetimibe
EP2414529A2 (en) 2009-04-01 2012-02-08 Matrix Laboratories Ltd Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
WO2011056895A1 (en) * 2009-11-03 2011-05-12 University Of Notre Dame Du Lac Ionic liquids comprising heteraromatic anions
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US9670237B2 (en) 2011-09-22 2017-06-06 Ut-Battelle, Llc Phosphonium-based ionic liquids and their use in the capture of polluting gases
WO2015048765A1 (en) 2013-09-30 2015-04-02 University Of Notre Dame Du Lac Compounds, complexes, compositions, methods and systems for heating and cooling
US10086331B2 (en) 2013-11-05 2018-10-02 University Of Notre Dame Du Lac Carbon dioxide capture using phase change ionic liquids
JP6803138B2 (ja) * 2014-10-22 2020-12-23 三星エスディアイ株式会社Samsung SDI Co., Ltd. ホスホニウム系化合物、それを含むエポキシ樹脂組成物、およびそれを用いて製造された半導体装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2107548T3 (es) * 1991-07-23 1997-12-01 Schering Corp Compuestos de beta-lactama sustituidos utiles como agentes hipocolesterolemicos y procedimientos para su preparacion.
FI960095L (fi) * 1993-07-09 1996-01-09 Schering Corp Menetelmä atsetidinonien syntetitoimiseksi
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
HRP20030498A2 (en) * 2000-12-21 2005-04-30 Aventis Pharma Deutschland Gmbh Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
TWI291957B (en) * 2001-02-23 2008-01-01 Kotobuki Pharmaceutical Co Ltd Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same

Also Published As

Publication number Publication date
DE502005001841D1 (de) 2007-12-13
EP1756049A1 (de) 2007-02-28
AR049184A1 (es) 2006-07-05
BRPI0510150A (pt) 2007-10-02
US20070149776A1 (en) 2007-06-28
TW200611896A (en) 2006-04-16
IL178991A0 (en) 2007-03-08
NZ551413A (en) 2009-07-31
MA28635B1 (fr) 2007-06-01
PT1756049E (pt) 2007-12-17
MXPA06013456A (es) 2007-03-01
WO2005113496A1 (de) 2005-12-01
US7488818B2 (en) 2009-02-10
JP2007538042A (ja) 2007-12-27
PL1756049T3 (pl) 2008-02-29
RU2380361C2 (ru) 2010-01-27
CA2567149A1 (en) 2005-12-01
CY1107425T1 (el) 2013-03-13
RS50539B (sr) 2010-05-07
AU2005245124A1 (en) 2005-12-01
RU2006145444A (ru) 2008-06-27
ES2294712T3 (es) 2008-04-01
EP1756049B1 (de) 2007-10-31
DK1756049T3 (da) 2008-02-25
HRP20070570T3 (en) 2008-01-31
ATE376997T1 (de) 2007-11-15
UY28912A1 (es) 2005-12-30
HK1103296A1 (zh) 2007-12-14

Similar Documents

Publication Publication Date Title
US6207822B1 (en) Process for the synthesis of azetidinones
FI80271B (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 1-sulfo-2-azetidinoniderivat, och nya som mellanprodukt anvaendbara 2-azetidinonderivat.
KR20070027554A (ko) 1,4-디페닐 아제티딘온 유도체의 제조방법
AU2002237522B2 (en) Beta-lactam compounds, process for reproducing the same and serum cholesterol-lowering agents containing the same
EP0707567B1 (en) Process for the synthesis of azetidinones
HUP0501164A2 (en) New industrial process for the production of ezetimibe
PT810225E (pt) Processo para a preparacao de paroxetina
CZ302395B6 (cs) Zpusob výroby (3R,4S)-1-(4-fluorfenyl)-3-[(3S)-3-(4-fluorfenyl)-3-hydroxypropyl)]-4-(4-hydroxyfenyl)-2-azetidinonu
US7563888B2 (en) Process for the preparation of diphenyl azetidinone derivatives
CZ2008317A3 (cs) Zpusob výroby (3R,4S)-1-(4-fluorfenyl)-3-[(3S)-3-(4-fluorfenyl)-3-hydroxypropyl)]-4-(4-hydroxyfenyl)-2-azetidinonu
CA2750801C (en) Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
JP5475832B2 (ja) Ｎ−（ｎ’−置換グリシル）−２−シアノピロリジン誘導体の製法
CN100509781C (zh) 制备1,4-二苯基氮杂环丁酮衍生物的方法
GB2137203A (en) Improvements in or relating to a process for producing b-lactam compounds
HK1103296B (en) Method for producing 1,4-diphenyl azetidinone derivatives
EP0573289B1 (en) Process for preparation of 2-oxo-1-piperidinyl derivatives
JPS6019763A (ja) アゼチジノンチオエステル類の製造法
JP4629973B2 (ja) 光学活性シクロプロピルアミン誘導体およびその製造方法
JP2922943B2 (ja) イミダゾリジノン誘導体
KR100283608B1 (ko) 1-베타메틸-2-포르밀카바페넴유도체의제조방법
JP2002316972A (ja) 光学活性３−シアノ−２−メチルプロパノール誘導体の製造法
DE102005010770A1 (de) Verfahren zur Herstellung von 1,4-Diphenylazetidinon-Derivaten
WO2002030893A1 (en) Processes for producing compound for antibacterial compound production therefrom and intermediate therefor
JPH09227511A (ja) ３−ブロモ−及び３，３−ジブロモ−４−オキソ−１−アゼチジンの新規誘導体、その製造方法及びこれを含有する医薬組成物
JPH07242608A (ja) ３−アミノペンタノアート誘導体及びその製造方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20061121

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid